Tag: PFE

Large investors have taken a positive outlook on Pfizer, with a majority of 52% opening trades with bullish expectations and ...

On March 6, 2024, a U.S. appeals court upheld the dismissal of a lawsuit brought by the conservative group, Do ...

As of March 1, 2024, analyst Louise Chen from Cantor Fitzgerald has once again given Pfizer (NYSE: PFE) an Overweight ...

On January 30, 2024, Pfizer delivered a surprising fourth-quarter profit, defying expectations despite a decline in COVID product sales. The ...

Pfizer, a leading pharmaceutical company, has recently reiterated its financial guidance for the full year of 2024. With revenues projected ...

On January 25, 2024, Pfizer Inc (NYSE:PFE) is gearing up to reveal its financial results for the fourth quarter of ...

As of January 23, 2024, the esteemed National Institute for Health and Care Excellence (NICE) has issued a noteworthy recommendation ...